 |
Lifestyle
changes key to diabetes prevention |
| |
EU-funded researchers and clinicians have gone
head to head with diabetes and it looks as though they are winning
the fight (Pubmed Diabetes) |
| |
|
|
Launch
of Europe-wide recommendations for preventing type 2 diabetes |
| |
Researchers and clinicians from across the UK
have been part of a pan-European team that has developed the first
Europe wide strategy for the prevention of type 2 diabetes (Genetic
Engineering & Biotechnology News) |
| |
|
|
Parents’ fear
of hypoglycaemia impacts on children’s diabetes management |
| |
Parents who live in fear of their children having
hypoglycaemic episodes might have a negative effect on their child’s diabetes control, says a new study (Diabetes UK) |
| |
|
|
Thirty-One
Novel Biomarkers as Predictors for Clinically Incident Diabetes |
| |
We identified novel biomarkers that were associated
with the risk of clinically incident diabetes over and above the
classic risk factors. This gives new insights into the pathogenesis
of diabetes and may help with targeting prevention and treatment
(PLoS) |
| |
|
|
Estimated
average glucose and self-monitored mean blood glucose are discordant
estimates of glycemic control |
| |
eAG underestimated MBG in low HGI patients and
overestimated MBG in high HGI patients. Disagreement between eAG
and MBG downloaded from patient glucose meters will cause confusion
if eAG is implemented for clinical use (Diabetes Care) |
| |
|
|
Hypoglycemia,
death associated with false GDH-PQQ test strip readings |
| |
Falsely elevated glucose levels — a
result of interfering sugars on glucose dehydrogenase pyrroloquinoline
quinone-based test strips — may pose a safety risk for patients, according to a recent review (Endocrine
Today) |
| |
|
|
Two
hormones are better than one? |
| |
An artificial pancreas or closed loop system
that can automatically regulate blood sugar levels by not only
giving insulin according to the body’s minute to minute needs, but also administering glucagon automatically as well
(JDRF) |
| |
|
|
Barriers
to Follow-up for Women with a History of Gestational Diabetes |
| |
We surveyed primary care providers (PCPs) and
obstetric and gynecology care providers (OBCPs) in a large health
system (American Journal of Perinatology) |
| |
|
|
No
Effect of the 1a,25-dihydroxyvitamin D3 on Beta Cell Residual
Function and Insulin Requirement in Adults with New-Onset Type
1 Diabetes |
| |
Treatment with 1,25(OH)2D3 at a daily dose of
0.25 µg was safe, but did not reduce loss of beta cell function (Diabetes Care) |
| |
|
|
Insulin
Resistance is Associated with Microangiopathy in Type 1 Diabetic
Patients |
| |
The results show that in patients with DM1,
treated from the initial diagnosis with intensive insulin therapy,
there is an independent relationship between IR and the diabetic
microangiopath (Experimental & Clinical Endocrinology & Diabetes) |
| |
|
|
Roche
expands its position in the growing insulin delivery systems
market |
| |
Roche and Elron Electronics Ltd have announced
that they have signed an agreement under which Roche will acquire
100% of Medingo Ltd, a majority-owned subsidiary of the Elron group
(Pharmacy Europe) |
| |
|
|
CureDM
Partners Novel Diabetes Treatment with Sanofi-Aventis |
| |
CureDM, LLC announced today that an agreement
has been signed with Sanofi-Aventis for the exclusive worldwide
license of Pancreate™, a novel islet neogenesis agent for the treatment of type 1 and type 2 diabetes
(PharmaLive) |
| |
|
|
Positive
results for diabetes drug |
| |
A diabetes drug developed by Sanofi-Aventis
could significantly improve blood sugar level control, a Phase
III study has found (Pharmacy Europe) |
| |
|
